E. Ohman J:or Asset Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.02M | Hold |
22,300
| – | – | 0.05% | 203 |
|
|
2026
Q1 | $1.79M | Hold |
22,300
| – | – | 0.05% | 198 |
|
|
2025
Q4 | $1.9M | Sell |
22,300
-3,755
| -14% | -$308K | 0.04% | 193 |
|
|
2025
Q3 | $2.03M | Hold |
26,055
| – | – | 0.05% | 180 |
|
|
2025
Q2 | $2.04M | Buy |
+26,055
| New | +$1.94M | 0.05% | 171 |
|
|
2025
Q1 | – | Sell |
-27,355
| Closed | -$2.03M | – | 420 |
|
|
2024
Q4 | $2.03M | Buy |
27,355
+2,600
| +11% | +$182K | 0.05% | 167 |
|
|
2024
Q3 | $1.63M | Sell |
24,755
-2,000
| -7% | -$145K | 0.04% | 186 |
|
|
2024
Q2 | $2.47M | Buy |
26,755
+1,700
| +7% | +$151K | 0.06% | 135 |
|
|
2024
Q1 | $2.39M | Buy |
25,055
+1,300
| +5% | +$109K | 0.06% | 137 |
|
|
2023
Q4 | $1.81M | Sell |
23,755
-3,600
| -13% | -$250K | 0.07% | 141 |
|
|
2023
Q3 | $1.9M | Sell |
27,355
-325,499
| -92% | -$26.2M | 0.07% | 141 |
|
|
2023
Q2 | $33.3M | Buy |
352,854
+84,949
| +32% | +$7.38M | 1.2% | 20 |
|
|
2023
Q1 | $22.2M | Buy |
267,905
+241,350
| +909% | +$19M | 0.87% | 32 |
|
|
2022
Q4 | $1.98M | Sell |
26,555
-1,100
| -4% | -$84.8K | 0.09% | 135 |
|
|
2022
Q3 | $2.29M | Hold |
27,655
| – | – | 0.1% | 119 |
|
|
2022
Q2 | $2.63M | Hold |
27,655
| – | – | 0.11% | 112 |
|
|
2022
Q1 | $3.26M | Sell |
27,655
-2,100
| -7% | -$236K | 0.11% | 112 |
|
|
2021
Q4 | $3.85M | Buy |
29,755
+2,800
| +10% | +$327K | 0.11% | 112 |
|
|
2021
Q3 | $3.05M | Buy |
26,955
+1,100
| +4% | +$126K | 0.1% | 121 |
|
|
2021
Q2 | $2.68M | Buy |
25,855
+2,000
| +8% | +$189K | 0.08% | 144 |
|
|
2021
Q1 | $2M | Sell |
23,855
-3,200
| -12% | -$271K | 0.07% | 151 |
|
|
2020
Q4 | $2.47M | Buy |
27,055
+400
| +2% | +$33.2K | 0.1% | 121 |
|
|
2020
Q3 | $2.13M | Buy |
26,655
+3,300
| +14% | +$257K | 0.11% | 117 |
|
|
2020
Q2 | $1.61M | Buy |
23,355
+1,500
| +7% | +$107K | 0.09% | 127 |
|
|
2020
Q1 | $1.37M | Sell |
21,855
-9,600
| -31% | -$692K | 0.1% | 111 |
|
|
2019
Q4 | $2.45M | Buy |
31,455
+2,655
| +9% | +$207K | 0.14% | 98 |
|
|
2019
Q3 | $2.11M | Buy |
28,800
+2,700
| +10% | +$190K | 0.13% | 100 |
|
|
2019
Q2 | $1.61M | Sell |
26,100
-600
| -2% | -$36.3K | 0.11% | 114 |
|
|
2019
Q1 | $1.7M | Sell |
26,700
-900
| -3% | -$51.4K | 0.11% | 106 |
|
|
2018
Q4 | $1.41M | Sell |
27,600
-63,495
| -70% | -$3.21M | 0.1% | 115 |
|
|
2018
Q3 | $5.29M | Sell |
91,095
-80,757
| -47% | -$3.95M | 0.34% | 63 |
|
|
2018
Q2 | $8.34M | Buy |
171,852
+91,848
| +115% | +$4.29M | 0.59% | 45 |
|
|
2018
Q1 | $3.72M | Buy |
80,004
+60,804
| +317% | +$2.64M | 0.3% | 66 |
|
|
2017
Q4 | $721K | Buy |
19,200
+3,300
| +21% | +$121K | 0.06% | 197 |
|
|
2017
Q3 | $579K | Buy |
15,900
+600
| +4% | +$22.9K | 0.05% | 230 |
|
|
2017
Q2 | $603K | Sell |
15,300
-3,000
| -16% | -$110K | 0.06% | 219 |
|
|
2017
Q1 | $574K | Buy |
18,300
+4,200
| +30% | +$131K | 0.07% | 225 |
|
|
2016
Q4 | $440K | Hold |
14,100
| – | – | 0.06% | 235 |
|
|
2016
Q3 | $567K | Sell |
14,100
-600
| -4% | -$22.6K | 0.08% | 173 |
|
|
2016
Q2 | $489K | Buy |
14,700
+4,200
| +40% | +$144K | 0.08% | 183 |
|
|
2016
Q1 | $309K | Sell |
10,500
-4,500
| -30% | -$124K | 0.06% | 244 |
|
|
2015
Q4 | $395K | Hold |
15,000
| – | – | 0.07% | 205 |
|
|
2015
Q3 | $355K | Hold |
15,000
| – | – | 0.1% | 205 |
|
|
2015
Q2 | $356K | Hold |
15,000
| – | – | 0.08% | 233 |
|
|
2015
Q1 | $356K | Buy |
15,000
+4,800
| +47% | +$108K | 0.08% | 240 |
|
|
2014
Q4 | $220K | Hold |
10,200
| – | – | 0.05% | 349 |
|
|
2014
Q3 | $174K | Sell |
10,200
-7,800
| -43% | -$123K | 0.04% | 389 |
|
|
2014
Q2 | $258K | Hold |
18,000
| – | – | 0.06% | 303 |
|
|
2014
Q1 | $223K | Hold |
18,000
| – | – | 0.06% | 339 |
|
|
2013
Q4 | $197K | Hold |
18,000
| – | – | 0.05% | 367 |
|
|
2013
Q3 | $209K | Hold |
18,000
| – | – | 0.05% | 360 |
|
|
2013
Q2 | $202K | Buy |
+18,000
| New | +$213K | 0.06% | 338 |
|
Other funds holding EW
WT
E. Ohman J:or Asset Management's EW Position: Q2 2026 in Review
E. Ohman J:or Asset Management held its Edwards Lifesciences (EW) position steady in Q2 2026 at 22,300 shares worth $2.02M. The position accounts for 0.05% of the portfolio, ranked #203.
E. Ohman J:or Asset Management first reported a position in EW in Q2 2013 and has held it in 52 quarters since. The position peaked at $33.3M in Q2 2023. 833 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- E. Ohman J:or Asset Management held 22,300 shares of Edwards Lifesciences worth $2.02M as of Q2 2026.
- E. Ohman J:or Asset Management left its Edwards Lifesciences share count unchanged in Q2 2026.
- Edwards Lifesciences made up 0.05% of E. Ohman J:or Asset Management's portfolio in Q2 2026, its #203 holding.
- E. Ohman J:or Asset Management first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 52 quarters since.
- E. Ohman J:or Asset Management's Edwards Lifesciences position peaked at $33.3M in Q2 2023.
- 833 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on E. Ohman J:or Asset Management's 13F filing for Q2 2026, filed 10 Jul 2026.